| 1 |
Weinstein, R. S., Chen, J. R., Powers, C. C., Stewart, S. A., Landes, R. D., Bellido, T., Jilka, R. L., Parfitt, A. M. and Manolagas, S. C. (2002) Promotion of osteoclast survival and antagonism of bisphosphonate-induced osteoclast apoptosis by glucocorticoids. J. Clin. Invest. 109, 1041-1048.
DOI
ScienceOn
|
| 2 |
Teitelbaum, S. L. (2007) Osteoclasts: what do they do and how do they do it? Am. J. Pathol. 170, 427-435.
DOI
ScienceOn
|
| 3 |
Teitelbaum, S. L. and Ross, F. P. (2003) Genetic regulation of osteoclast development and function. Nat. Rev. Genet. 4, 638-649.
DOI
ScienceOn
|
| 4 |
Faccio, R., Novack, D. V., Zallone, A., Ross, F. P. and Teitelbaum, S. L. (2003) Dynamic changes in the osteoclast cytoskeleton in response to growth factors and cell attachment are controlled by beta3 integrin. J. Cell Biol. 162, 499-509.
DOI
ScienceOn
|
| 5 |
Nakamura, I., Kadono, Y., Takayanagi, H., Jimi, E., Miyazaki, T., Oda, H., Nakamura, K., Tanaka, S., Rodan, G. A. and Duong le, T. (2002) IL-1 regulates cytoskeletal organization in osteoclasts via TNF receptor-associated factor 6/c-Src complex. J. Immunol. 168, 5103-5109.
DOI
|
| 6 |
Sakai, H., Chen, Y., Itokawa, T., Yu, K. P., Zhu, M. L. and Insogna, K. (2006) Activated c-Fms recruits Vav and Rac during CSF-1-induced cytoskeletal remodeling and spreading in osteoclasts. Bone 39, 1290-1301.
DOI
ScienceOn
|
| 7 |
Ory, S., Brazier, H., Pawlak, G. and Blangy, A. (2008) Rho GTPases in osteoclasts: orchestrators of podosome arrangement. Eur. J. Cell Biol. 87, 469-477.
DOI
ScienceOn
|
| 8 |
Purpura, K. A., Aubin, J. E. and Zandstra, P. W. (2004) Sustained in vitro expansion of bone progenitors is cell density dependent. Stem Cells 22, 39-50.
DOI
ScienceOn
|
| 9 |
Teitelbaum, S. L. (2000) Bone resorption by osteoclasts. Science 289, 1504-1508.
DOI
ScienceOn
|
| 10 |
Hofbauer, L. C., Gori, F., Riggs, B. L., Lacey, D. L., Dunstan, C. R., Spelsberg, T. C. and Khosla, S. (1999) Stimulation of osteoprotegerin ligand and inhibition of osteoprotegerin production by glucocorticoids in human osteoblastic lineage cells: potential paracrine mechanisms of glucocorticoid-induced osteoporosis. Endocrinology 140, 4382-4389.
DOI
ScienceOn
|
| 11 |
Rubin, J., Biskobing, D. M., Jadhav, L., Fan, D., Nanes, M. S., Perkins, S. and Fan, X. (1998) Dexamethasone promotes expression of membrane-bound macrophage colony-stimulating factor in murine osteoblast-like cells. Endocrinology 139, 1006-1012.
DOI
ScienceOn
|
| 12 |
Dempster, D. W. (1989) Bone histomorphometry in glucocorticoid-induced osteoporosis. J. Bone Miner Res. 4, 137-141.
DOI
|
| 13 |
Prummel, M. F., Wiersinga, W. M., Lips, P., Sanders, G. T. and Sauerwein, H. P. (1991) The course of biochemical parameters of bone turnover during treatment with corticosteroids. J. Clin. Endocrinol. Metab. 72, 382-386.
DOI
|
| 14 |
Kim, Y. H., Jun, J. H., Woo, K. M., Ryoo, H. M., Kim, G. S. and Baek, J. H. (2006) Dexamethasone inhibits the formation of multinucleated osteoclasts via down-regulation of beta3 integrin expression. Arch. Pharm. Res. 29, 691-698.
DOI
ScienceOn
|
| 15 |
Kim, H. J., Zhao, H., Kitaura, H., Bhattacharyya, S., Brewer, J. A., Muglia, L. J., Ross, F. P. and Teitelbaum, S. L. (2006) Glucocorticoids suppress bone formation via the osteoclast. J. Clin. Invest. 116, 2152-2160.
DOI
ScienceOn
|
| 16 |
Canalis, E. (1996) Clinical review 83: mechanisms of glucocorticoid action in bone: implications to glucocorticoid-induced osteoporosis. J. Clin. Endocrinol. Metab. 81, 3441-3447.
DOI
|
| 17 |
Pereira, R. C., Delany, A. M. and Canalis, E. (2004) CCAAT/enhancer binding protein homologous protein (DDIT3) induces osteoblastic cell differentiation. Endocrinology 145, 1952-1960.
DOI
ScienceOn
|
| 18 |
Pereira, R. C., Delany, A. M. and Canalis, E. (2002) Effects of cortisol and bone morphogenetic protein-2 on stromal cell differentiation: correlation with CCAAT-enhancer binding protein expression. Bone 30, 685-691.
DOI
ScienceOn
|
| 19 |
Pereira, R. M., Delany, A. M. and Canalis, E. (2001) Cortisol inhibits the differentiation and apoptosis of osteoblasts in culture. Bone 28, 484-490.
DOI
ScienceOn
|
| 20 |
Ito, S., Suzuki, N., Kato, S., Takahashi, T. and Takagi, M. (2007) Glucocorticoids induce the differentiation of a mesenchymal progenitor cell line, ROB-C26 into adipocytes and osteoblasts, but fail to induce terminal osteoblast differentiation. Bone 40, 84-92.
DOI
ScienceOn
|
| 21 |
Wu, Z., Bucher, N. L. and Farmer, S. R. (1996) Induction of peroxisome proliferator-activated receptor gamma during the conversion of 3T3 fibroblasts into adipocytes is mediated by C/EBPbeta, C/EBPdelta, and glucocorticoids. Mol. Cell Biol. 16, 4128-4136.
|
| 22 |
Aubin, J. E. (1999) Osteoprogenitor cell frequency in rat bone marrow stromal populations: role for heterotypic cell-cell interactions in osteoblast differentiation. J. Cell Biochem. 72, 396-410.
DOI
ScienceOn
|
| 23 |
Eijken, M., Koedam, M., van Driel, M., Buurman, C. J., Pols, H. A. and van Leeuwen, J. P. (2006) The essential role of glucocorticoids for proper human osteoblast differentiation and matrix mineralization. Mol. Cell Endocrinol. 248, 87-93.
DOI
ScienceOn
|
| 24 |
Kogianni, G., Mann, V., Ebetino, F., Nuttall, M., Nijweide, P., Simpson, H. and Noble, B. (2004) Fas/CD95 is associated with glucocorticoid-induced osteocyte apoptosis. Life Sci. 75, 2879-2895.
DOI
ScienceOn
|
| 25 |
Ogawa, S., Lozach, J., Benner, C., Pascual, G., Tangirala, R. K., Westin, S., Hoffmann, A., Subramaniam, S., David, M., Rosenfeld, M. G. and Glass, C. K. (2005) Molecular determinants of crosstalk between nuclear receptors and toll-like receptors. Cell 122, 707-721.
DOI
ScienceOn
|
| 26 |
Weinstein, R. S., Jilka, R. L., Parfitt, A. M. and Manolagas, S. C. (1998) Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids. Potential mechanisms of their deleterious effects on bone. J. Clin. Invest. 102, 274-282.
DOI
ScienceOn
|
| 27 |
Espina, B., Liang, M., Russell, R. G. and Hulley, P. A. (2008) Regulation of bim in glucocorticoid-mediated osteoblast apoptosis. J. Cell Physiol. 215, 488-496.
DOI
ScienceOn
|
| 28 |
Liu, Y., Encinas, M., Comella, J. X., Aldea, M. and Gallego, C. (2004) Basic helix-loop-helix proteins bind to TrkB and p21(Cip1) promoters linking differentiation and cell cycle arrest in neuroblastoma cells. Mol. Cell Biol. 24, 2662-2672.
DOI
|
| 29 |
O'Brien, C. A., Jia, D., Plotkin, L. I., Bellido, T., Powers, C. C., Stewart, S. A., Manolagas, S. C. and Weinstein, R. S. (2004) Glucocorticoids act directly on osteoblasts and osteocytes to induce their apoptosis and reduce bone formation and strength. Endocrinology 145, 1835-1841.
DOI
ScienceOn
|
| 30 |
Smith, E., Coetzee, G. A. and Frenkel, B. (2002) Glucocorticoids inhibit cell cycle progression in differentiating osteoblasts via glycogen synthase kinase-3beta. J. Biol. Chem. 277, 18191-18197.
DOI
ScienceOn
|
| 31 |
Li, C., Li, Y., Liu, H., Sun, Z., Lu, J. and Zhao, Y. (2008) Glucocorticoid repression of human with-no-lysine (K) kinase-4 gene expression is mediated by the negative response elements in the promoter. J. Mol. Endocrinol. 40, 3-12.
DOI
ScienceOn
|
| 32 |
Ruppert, S., Boshart, M., Bosch, F. X., Schmid, W., Fournier, R. E. and Schutz, G. (1990) Two genetically defined transacting loci coordinately regulate overlapping sets of liver-specific genes. Cell 61, 895-904.
DOI
ScienceOn
|
| 33 |
Drouin, J., Sun, Y. L., Chamberland, M., Gauthier, Y., De Lean, A., Nemer, M. and Schmidt, T. J. (1993) Novel glucocorticoid receptor complex with DNA element of the hormone-repressed POMC gene. EMBO J. 12, 145-156.
|
| 34 |
Stromstedt, P. E., Poellinger, L., Gustafsson, J. A. and Carlstedt-Duke, J. (1991) The glucocorticoid receptor binds to a sequence overlapping the TATA box of the human osteocalcin promoter: a potential mechanism for negative regulation. Mol. Cell Biol. 11, 3379-3383.
DOI
|
| 35 |
Liberman, A. C., Druker, J., Perone, M. J. and Arzt, E. (2007) Glucocorticoids in the regulation of transcription factors that control cytokine synthesis. Cytokine Growth Factor Rev. 18, 45-56.
DOI
ScienceOn
|
| 36 |
Liberman, A. C., Druker, J., Refojo, D., Holsboer, F. and Arzt, E. (2009) Glucocorticoids inhibit GATA-3 phosphorylation and activity in T cells. FASEB J. 23, 1558-1571.
DOI
ScienceOn
|
| 37 |
Liberman, A. C., Refojo, D., Druker, J., Toscano, M., Rein, T., Holsboer, F. and Arzt, E. (2007) The activated glucocorticoid receptor inhibits the transcription factor T-bet by direct protein-protein interaction. FASEB J. 21, 1177-1188.
DOI
ScienceOn
|
| 38 |
Lukert, B. P. and Raisz, L. G. (1990) Glucocorticoid-induced osteoporosis: pathogenesis and management. Ann. Intern. Med. 112, 352-364.
DOI
ScienceOn
|
| 39 |
Luengo, M., Picado, C., Piera, C., Guanabens, N., Montserrat, J. M., Rivera, J. and Setoain, J. (1991) Intestinal calcium absorption and parathyroid hormone secretion in asthmatic patients on prolonged oral or inhaled steroid treatment. Eur. Respir. J. 4, 441-444.
|
| 40 |
Canalis, E., Bilezikian, J. P., Angeli, A. and Giustina, A. (2004) Perspectives on glucocorticoid-induced osteoporosis. Bone 34, 593-598.
DOI
ScienceOn
|
| 41 |
Paz-Pacheco, E., Fuleihan, G. E. and LeBoff, M. S. (1995) Intact parathyroid hormone levels are not elevated in glucocorticoid-treated subjects. J. Bone Miner Res. 10, 1713-1718.
DOI
|
| 42 |
Hollenberg, S. M., Weinberger, C., Ong, E. S., Cerelli, G., Oro, A., Lebo, R., Thompson, E. B., Rosenfeld, M. G. and Evans, R. M. (1985) Primary structure and expression of a functional human glucocorticoid receptor cDNA. Nature 318, 635-641.
DOI
ScienceOn
|
| 43 |
Miesfeld, R., Okret, S., Wikstrom, A. C., Wrange, O., Gustafsson, J. A. and Yamamoto, K. R. (1984) Characterization of a steroid hormone receptor gene and mRNA in wildtype and mutant cells. Nature 312, 779-781.
DOI
ScienceOn
|
| 44 |
Kumar, R. and Thompson, E. B. (2005) Gene regulation by the glucocorticoid receptor: structure: function relationship. J. Steroid. Biochem. Mol. Biol. 94, 383-394.
DOI
ScienceOn
|
| 45 |
Reichardt, H. M. and Schutz, G. (1998) Glucocorticoid signalling--multiple variations of a common theme. Mol. Cell Endocrinol. 146, 1-6.
DOI
ScienceOn
|
| 46 |
Wang, Y., Lebowitz, D., Sun, C., Thang, H., Grynpas, M. D. and Glogauer, M. (2008) Identifying the relative contributions of Rac1 and Rac2 to osteoclastogenesis. J. Bone Miner Res. 23, 260-270.
DOI
|
| 47 |
Manolagas, S. C. and Weinstein, R. S. (1999) New developments in the pathogenesis and treatment of steroid-induced osteoporosis. J. Bone Miner Res. 14, 1061-1066.
DOI
ScienceOn
|
| 48 |
Weinstein, R. S. (2001) Glucocorticoid-induced osteoporosis. Rev. Endocr. Metab. Disord. 2, 65-73.
DOI
ScienceOn
|
| 49 |
Okumura, S., Mizoguchi, T., Sato, N., Yamaki, M., Kobayashi, Y., Yamauchi, H., Ozawa, H., Udagawa, N. and Takahashi, N. (2006) Coordination of microtubules and the actin cytoskeleton is important in osteoclast function, but calcitonin disrupts sealing zones without affecting microtubule networks. Bone 39, 684-693.
DOI
ScienceOn
|
| 50 |
Chellaiah, M. A., Soga, N., Swanson, S., McAllister, S., Alvarez, U., Wang, D., Dowdy, S. F. and Hruska, K. A. (2000) Rho-A is critical for osteoclast podosome organization, motility, and bone resorption. J. Biol. Chem. 275, 11993-12002.
DOI
ScienceOn
|
| 51 |
Etienne-Manneville, S. and Hall, A. (2002) Rho GTPases in cell biology. Nature 420, 629-635.
DOI
ScienceOn
|
| 52 |
Hornstein, I., Alcover, A. and Katzav, S. (2004) Vav proteins, masters of the world of cytoskeleton organization. Cell Signal 16, 1-11.
DOI
ScienceOn
|
| 53 |
Rossman, K. L., Der, C. J. and Sondek, J. (2005) GEF means go: turning on RHO GTPases with guanine nucleotide-exchange factors. Nat. Rev. Mol. Cell Biol. 6, 167-180.
DOI
ScienceOn
|
| 54 |
Faccio, R., Teitelbaum, S. L., Fujikawa, K., Chappel, J., Zallone, A., Tybulewicz, V. L., Ross, F. P. and Swat, W. (2005) Vav3 regulates osteoclast function and bone mass. Nat. Med. 11, 284-290.
DOI
ScienceOn
|
| 55 |
Patschan, D., Loddenkemper, K. and Buttgereit, F. (2001) Molecular mechanisms of glucocorticoid-induced osteoporosis. Bone 29, 498-505.
DOI
ScienceOn
|
| 56 |
Destaing, O., Saltel, F., Gilquin, B., Chabadel, A., Khochbin, S., Ory, S. and Jurdic, P. (2005) A novel Rho-mDia2-HDAC6 pathway controls podosome patterning through microtubule acetylation in osteoclasts. J. Cell Sci. 118, 2901-2911.
DOI
ScienceOn
|
| 57 |
Jia, D., O'Brien, C. A., Stewart, S. A., Manolagas, S. C. and Weinstein, R. S. (2006) Glucocorticoids act directly on osteoclasts to increase their life span and reduce bone density. Endocrinology 147, 5592-5599.
DOI
ScienceOn
|
webmaster
